Stock listing
KRX:054950 JVM Co., Ltd. (제이브이엠) 주가
Follow JVM Co., Ltd. into a list and get an email when it puts out news.
Share price · KRX:054950
₩25,550 KRW +900 (+3.7%)
Close on Nov 20, 2026
- Day range
- ₩25,300 – ₩25,900 KRWNov 20, 2026
- Volume
- 23,102 sharesNov 20, 2026
- Market cap
- ₩294.8B KRWAt the close on Nov 20, 2026 · price × 11.54M shares outstanding
- 52-week range
- ₩19,930 – ₩27,600 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩411.9M KRWMedian day 13,400 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:054950 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩25,550 | +900 | +3.7% | ₩25,450 | ₩25,900 | ₩25,300 | 23,102 | |
| ₩24,650 | 0 | 0.0% | ₩24,700 | ₩25,000 | ₩24,550 | 12,450 | |
| ₩24,650 | -250 | -1.0% | ₩24,900 | ₩25,150 | ₩24,550 | 12,615 | |
| ₩24,900 | -400 | -1.6% | ₩25,450 | ₩25,450 | ₩24,750 | 10,969 | |
| ₩25,300 | -250 | -1.0% | ₩25,600 | ₩25,900 | ₩25,100 | 21,946 | |
| ₩25,550 | -100 | -0.4% | ₩25,500 | ₩26,450 | ₩25,250 | 24,725 | |
| ₩25,650 | +1,300 | +5.3% | ₩24,550 | ₩25,850 | ₩24,500 | 50,226 | |
| ₩24,350 | +50 | +0.2% | ₩24,400 | ₩24,700 | ₩24,150 | 13,236 | |
| ₩24,300 | 0 | 0.0% | ₩24,300 | ₩24,800 | ₩24,250 | 19,096 | |
| ₩24,300 | -300 | -1.2% | ₩24,100 | ₩24,700 | ₩23,700 | 27,213 | |
| ₩24,600 | +50 | +0.2% | ₩24,800 | ₩25,100 | ₩23,800 | 39,197 | |
| ₩24,550 | +350 | +1.4% | ₩24,400 | ₩24,750 | ₩23,500 | 31,923 | |
| ₩24,200 | +600 | +2.5% | ₩23,300 | ₩24,350 | ₩23,250 | 37,914 | |
| ₩23,600 | +450 | +1.9% | ₩23,000 | ₩24,000 | ₩22,950 | 17,168 | |
| ₩23,150 | +600 | +2.7% | ₩22,750 | ₩23,650 | ₩22,300 | 30,311 | |
| ₩22,550 | 0 | 0.0% | ₩22,750 | ₩22,800 | ₩22,200 | 13,955 | |
| ₩22,550 | +250 | +1.1% | ₩22,350 | ₩22,950 | ₩22,350 | 9,576 | |
| ₩22,300 | +600 | +2.8% | ₩22,000 | ₩22,350 | ₩21,900 | 5,975 | |
| ₩21,700 | -400 | -1.8% | ₩22,150 | ₩22,150 | ₩21,500 | 14,502 | |
| ₩22,100 | +100 | +0.5% | ₩21,900 | ₩22,200 | ₩21,650 | 7,881 | |
| ₩22,000 | -650 | -2.9% | ₩23,000 | ₩23,000 | ₩22,000 | 12,932 | |
| ₩22,650 | -150 | -0.7% | ₩23,000 | ₩23,250 | ₩22,650 | 17,101 | |
| ₩22,800 | -800 | -3.4% | ₩23,750 | ₩23,850 | ₩22,400 | 19,315 | |
| ₩23,600 | -50 | -0.2% | ₩23,650 | ₩23,750 | ₩23,200 | 12,725 | |
| ₩23,650 | +350 | +1.5% | ₩23,500 | ₩24,250 | ₩23,500 | 11,465 | |
| ₩23,300 | -1,000 | -4.1% | ₩24,250 | ₩24,300 | ₩23,300 | 32,858 | |
| ₩24,300 | -50 | -0.2% | ₩24,300 | ₩24,900 | ₩23,500 | 26,814 | |
| ₩24,350 | +100 | +0.4% | ₩24,200 | ₩24,400 | ₩23,750 | 28,611 | |
| ₩24,250 | +50 | +0.2% | ₩24,250 | ₩24,750 | ₩24,200 | 21,519 | |
| ₩24,200 | -150 | -0.6% | ₩24,250 | ₩24,600 | ₩24,050 | 15,713 | |
| ₩24,350 | +50 | +0.2% | ₩24,300 | ₩24,550 | ₩24,200 | 12,329 | |
| ₩24,300 | -150 | -0.6% | ₩24,300 | ₩24,550 | ₩24,000 | 17,775 | |
| ₩24,450 | +600 | +2.5% | ₩24,450 | ₩24,500 | ₩24,050 | 15,744 | |
| ₩23,850 | +200 | +0.8% | ₩23,900 | ₩24,150 | ₩23,750 | 10,834 | |
| ₩23,650 | -300 | -1.3% | ₩24,000 | ₩24,150 | ₩23,650 | 8,260 | |
| ₩23,950 | +750 | +3.2% | ₩23,300 | ₩23,950 | ₩23,100 | 13,564 | |
| ₩23,200 | +200 | +0.9% | ₩23,150 | ₩23,400 | ₩23,000 | 5,111 | |
| ₩23,000 | 0 | 0.0% | ₩23,200 | ₩23,300 | ₩22,900 | 8,672 | |
| ₩23,000 | 0 | 0.0% | ₩23,200 | ₩23,350 | ₩23,000 | 8,615 | |
| ₩23,000 | -50 | -0.2% | ₩23,000 | ₩23,250 | ₩22,850 | 13,609 | |
| ₩23,050 | -50 | -0.2% | ₩23,200 | ₩23,600 | ₩23,000 | 11,285 | |
| ₩23,100 | -50 | -0.2% | ₩22,950 | ₩23,350 | ₩22,900 | 6,544 | |
| ₩23,150 | +100 | +0.4% | ₩23,150 | ₩23,300 | ₩22,900 | 9,354 | |
| ₩23,050 | -500 | -2.1% | ₩23,550 | ₩23,550 | ₩22,950 | 19,387 | |
| ₩23,550 | +150 | +0.6% | ₩23,400 | ₩23,650 | ₩23,250 | 17,805 | |
| ₩23,400 | +200 | +0.9% | ₩23,100 | ₩23,700 | ₩23,050 | 35,003 | |
| ₩23,200 | -350 | -1.5% | ₩23,500 | ₩23,500 | ₩23,200 | 39,035 | |
| ₩23,550 | +150 | +0.6% | ₩23,350 | ₩23,700 | ₩23,250 | 11,717 | |
| ₩23,400 | 0 | 0.0% | ₩23,450 | ₩23,700 | ₩23,250 | 21,148 | |
| ₩23,400 | +150 | +0.6% | ₩23,650 | ₩23,650 | ₩23,300 | 10,476 | |
| ₩23,250 | -300 | -1.3% | ₩23,450 | ₩23,800 | ₩23,150 | 12,484 | |
| ₩23,550 | -250 | -1.1% | ₩23,800 | ₩24,000 | ₩23,400 | 12,849 | |
| ₩23,800 | -250 | -1.0% | ₩23,800 | ₩24,050 | ₩23,600 | 10,379 | |
| ₩24,050 | +50 | +0.2% | ₩24,000 | ₩24,400 | ₩24,000 | 9,943 | |
| ₩24,000 | -50 | -0.2% | ₩24,150 | ₩24,150 | ₩23,400 | 9,137 | |
| ₩24,050 | +250 | +1.1% | ₩23,950 | ₩24,150 | ₩23,650 | 6,470 | |
| ₩23,800 | -400 | -1.7% | ₩24,400 | ₩24,650 | ₩23,800 | 8,464 | |
| ₩24,200 | -150 | -0.6% | ₩24,350 | ₩24,500 | ₩24,100 | 8,651 | |
| ₩24,350 | +50 | +0.2% | ₩24,150 | ₩24,400 | ₩23,550 | 11,874 | |
| ₩24,300 | +800 | +3.4% | ₩23,850 | ₩24,900 | ₩23,450 | 30,479 | |
| ₩23,500 | -550 | -2.3% | ₩24,050 | ₩24,050 | ₩23,150 | 17,765 | |
| ₩24,050 | +200 | +0.8% | ₩23,900 | ₩24,400 | ₩23,750 | 9,941 |
Splits
1 split · KRX:054950 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split |
- Ticker
- KRX:054950
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- KRX
- Currency
- KRW
What changed lately
Latest news release · Feb 4, 2026
Jvm Co Ltd Q4 Operating Profit 6 Billion Won, Down 35% From Year Earlier
Latest news
Jvm Co Ltd Q4 Operating Profit 6 Billion Won, Down 35% From Year Earlier
Feb 4, 2026
Closed ₩25,450 (+1.8%) on Feb 5, 2026
JVM Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 1 in the last 12 months · 2 in all · newest Feb 4, 2026 · oldest 2025
Valuation
P/E 9.6× against a median of 20.7×: 2nd lowest of 6 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩143.3B KRW
- P/E
- 9.6×
- EV/sales
- 0.8×
- EV/EBITDA
- 3.4×
- Price/book
- 1.2×
- Gross margin
- 42.7%
- Operating margin
- 20.5%
- Net margin
- 17.4%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| JVM Co., Ltd. · KRX:054950 | US$219.0M | US$106.5M | 9.6× | 0.8× | 3.4× | 1.2× | 17.4% | 0.0× | n/a |
| Jiangsu Nanfang Medical Co., Ltd. Class A · SSE:603880 | US$232.0M | US$233.5M | n/a | 2.8× | n/a | 10.4× | −18.9% | 0.3× | n/a |
| Jenscare Scientific Co. Ltd. Class H · HKEX:9877 | US$224.5M | US$168.3M | n/a | 12.7× | n/a | 2.0× | −299.4% | 0.1× | n/a |
| ClearPoint Neuro Inc. · NASDAQ:CLPT | US$221.5M | US$226.2M | n/a | 5.0× | n/a | 8.1× | −79.4% | 1.9× | 1.97 |
| Utah Medical Products, Inc. · NASDAQ:UTMD | US$220.6M | US$135.6M | 20.7× | 3.9× | n/a | 1.8× | 30.5% | 0.0× | 0.31 |
| Bioteque Corporation · TPEX:4107 | US$217.6M | US$163.2M | 12.2× | 2.4× | 6.0× | 2.0× | 26.5% | 0.0× | n/a |
| Stille AB · OMXSTO:STIL | US$217.5M | US$200.8M | 23.1× | 2.9× | n/a | 2.8× | 13.5% | 0.0× | n/a |
| Touchstone International Medical Science Co. Ltd. Class A · SSE:688013 | US$216.1M | US$180.6M | 50.4× | 4.7× | n/a | 2.9× | 11.2% | 0.1× | n/a |
| Won Tech Co.,Ltd. · KRX:336570 | US$213.0M | US$147.6M | 7.2× | 1.2× | 4.4× | 1.7× | 23.9% | 0.2× | n/a |
| Spectral Medical Inc · TSX:EDT | US$210.9M | US$228.2M | n/a | 127× | n/a | n/a | n/a | n/a | 0.51 |
| MicroPort CardioFlow Medtech Corporation · HKEX:2160 | US$207.9M | −US$915.3M | n/a | −2.1× | −82.9× | 0.1× | −33.0% | 0.1× | n/a |
| Median of the others | US$217.6M | US$174.4M | 20.7× | 3.4× | 4.4× | 2.0× | 11.2% | 0.1× | 0.51 |
Forecasts
Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.
- Price target
- 34000.00 KRW · Analysts' mean
- EPS, year to Dec 2026
- 2949.00 · 3 analysts
- Revenue, year to Dec 2026
- 182B · 2 analysts
Team and board
| Officer | Role |
|---|---|
| Sang-Wook Kim | CEO |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2026 | Apr 27, 2026 · Before open | +0.2% |
| Q3 2025 | Oct 29, 2025 · Before open | +0.6% |
| Q2 2025 | Jul 23, 2025 · Before open | +0.2% |
| Q1 2025 | Apr 29, 2025 · Before open | +2.4% |
| Q4 2024 | Feb 6, 2025 · Before open | +2.6% |
| Q3 2024 | Oct 31, 2024 · After close | −4.7% |
| Q2 2024 | Jul 25, 2024 · After close | −0.4% |
| Q1 2024 | Apr 30, 2024 · After close | −0.8% |
| Q3 2023 | Oct 26, 2023 · After close | −16.8% |
| Q2 2023 | Jul 27, 2023 · After close | +4.2% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2023 | Apr 27, 2023 · After close | +12.5% |
| Q4 2022 | Jan 27, 2023 · Before open | −1.6% |
| Q3 2022 | Oct 27, 2022 · Before open | +1.2% |
| Q2 2022 | Jul 28, 2022 · Before open | +0.3% |
| Q1 2022 | Apr 28, 2022 · Before open | −0.3% |
| Q4 2021 | Jan 27, 2022 · Before open | −1.8% |
| Q3 2021 | Oct 28, 2021 · Before open | −1.2% |
| Quarter to Jun 30, 2021 | Jul 29, 2021 · Before open | −0.3% |
| Quarter to Mar 31, 2021 | Apr 30, 2021 · Before open | −2.6% |
| Quarter to Dec 31, 2020 | Jan 29, 2021 · Before open | −3.8% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 173.1B | 159.4B | 157.1B | 142.0B | 115.8B | 115.4B | 110.1B | 103.6B | 106.2B | 98.1B |
| Cost of revenue | 102.3B | 95.7B | 94.5B | 90.8B | 76.6B | 73.4B | 71.0B | 63.4B | 61.1B | 55.5B |
| Gross profit | 70.8B | 63.7B | 62.6B | 51.2B | 39.2B | 42.0B | 39.1B | 40.2B | 45.1B | 42.6B |
| Research and development | 10.3B | 9.84B | 8.71B | 7.92B | 6.40B | 6.41B | 6.66B | 5.61B | 3.42B | 2.07B |
| Selling, general and administrative | 11.1B | 21.2B | 22.2B | 19.2B | 18.5B | 18.2B | 19.8B | 19.6B | 21.0B | 23.4B |
| Operating income | 33.3B | 30.7B | 29.8B | 20.0B | 11.2B | 12.9B | 5.94B | 9.28B | 11.8B | 11.8B |
| Depreciation and amortization | 4.91B | 3.93B | 4.90B | 3.83B | 4.42B | 5.67B | 7.03B | 6.81B | 6.29B | 3.53B |
| EBITDA | 38.2B | 34.6B | 34.7B | 23.8B | 15.6B | 18.6B | 13.0B | 16.1B | 18.1B | 15.3B |
| Interest expense | 951.2M | 1.46B | 1.27B | 325.1M | 169.3M | 147.5M | 0 | 0 | 0 | 0 |
| Income before tax | 36.2B | 34.7B | 33.1B | 21.3B | 9.40B | 12.6B | 8.37B | 10.8B | 14.8B | 12.1B |
| Income tax | 2.18B | 2.57B | 2.65B | 3.30B | 1.01B | |||||
| Net income | 28.4B | 28.8B | 26.2B | 15.8B | 8.95B | 10.4B | 5.80B | 8.16B | 11.5B | 11.1B |
| Earnings per share, basic | 2,461.44 | 2,504.29 | 2,278.49 | 1,367.99 | 777.09 | 906.54 | 496.73 | 686.73 | 947.53 | 912.28 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 8.67B | 12.5B | 11.6B | 7.23B | 6.84B | 7.68B | 2.82B | 820.5M | 2.59B | 8.61B |
| Short-term investments | 126.0B | 94.0B | 77.0B | 60.7B | 47.7B | 31.6B | 22.5B | 21.1B | 13.2B | 17.3B |
| Receivables | 31.3B | 33.0B | 21.7B | 17.4B | 17.4B | 20.5B | 26.6B | 29.2B | 29.0B | 22.9B |
| Inventory | 34.6B | 30.2B | 28.2B | 28.7B | 24.0B | 22.7B | 24.9B | 22.7B | 20.4B | 17.6B |
| Current assets | 206.2B | 176.5B | 147.6B | 119.5B | 99.5B | 86.4B | 81.6B | 75.3B | 67.6B | 69.4B |
| Property, plant and equipment | 68.8B | 68.9B | 70.0B | 69.9B | 72.7B | 57.5B | 56.5B | 57.2B | 55.3B | |
| Goodwill | 954.3M | |||||||||
| Total assets | 319.1B | 284.8B | 257.5B | 231.7B | 211.0B | 199.9B | 180.1B | 176.7B | 172.4B | 176.6B |
| Accounts payable | 20.7B | 22.7B | 18.1B | 18.8B | 24.6B | 20.6B | 23.8B | 17.6B | 10.4B | 8.22B |
| Current liabilities | 77.7B | 79.3B | 74.6B | 70.3B | 63.9B | 59.9B | 54.3B | 49.3B | 46.9B | 55.8B |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.96B | ||
| Total debt | 26.1B | 18.8B | 40.2B | |||||||
| Total liabilities | 85.2B | 82.5B | 78.0B | 73.6B | 67.6B | 62.6B | 56.5B | 53.6B | 51.3B | 64.5B |
| Shareholders' equity | 233.9B | 202.3B | 179.5B | 158.1B | 143.5B | 137.4B | 123.6B | 123.2B | 121.1B | 112.2B |
| Shares outstanding | 11.5M | 11.5M | 11.5M | 11.5M | 11.5M | 11.5M | 11.7M | 11.9M | 12.1M | 12.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 30.4B | 25.9B | 29.9B | 14.8B | 26.1B | 19.8B | 18.6B | 19.9B | 18.0B | 14.9B |
| Capital spending | -4.87B | -3.67B | -3.29B | -4.70B | -5.12B | -7.12B | -4.76B | -4.44B | -6.27B | -8.32B |
| Free cash flow | 25.5B | 22.3B | 26.6B | 10.1B | 21.0B | 10.7B | 13.8B | 15.5B | 11.7B | 6.59B |
| Cash from investing | -18.6B | -20.0B | -18.4B | -22.6B | -17.8B | -6.79B | -14.6B | -7.09B | -9.72B | |
| Cash from financing | -6.89B | -5.61B | 4.05B | -4.36B | 2.70B | -9.67B | -7.69B | -16.9B | 1.18B | |
| Dividends paid | -5.76B | -4.61B | -3.46B | -2.30B | -2.30B | -2.34B | -2.08B | -1.81B | -608.3M | -1.25B |
| Share buybacks | 0 | -1.95B | -3.37B | -3.73B | -1.51B | -2.62B | ||||
| Change in cash | -3.79B | 877.5M | 4.34B | 406.0M | -856.4M | 4.66B | 2.11B | -2.42B | -5.98B | 6.51B |
Cap table
Built by 6ix from JVM Co., Ltd.’s releases
- Common shares
- 11,536,989
- Fully diluted
- 11,536,989
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 11,536,989 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 11,536,989 |
Log in to ask 6ix AI your own questions about JVM Co., Ltd.